JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antoch, G.
Right arrow Articles by Bockisch, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antoch, G.
Right arrow Articles by Bockisch, A.
Journal of Nuclear Medicine Vol. 43 No. 10 1339-1342
© 2002 by Society of Nuclear Medicine


Brief Communication

Focal Tracer Uptake: A Potential Artifact in Contrast-Enhanced Dual-Modality PET/CT Scans

Gerald Antoch, MD1, Lutz S. Freudenberg, MD2, Thomas Egelhof, MD1, Jörg Stattaus, MD1, Walter Jentzen, PhD2, Jörg F. Debatin, MD, MBA1 and Andreas Bockisch, MD, PhD2

1 Department of Diagnostic and Interventional Radiology, University Hospital Essen, Essen, Germany
2 Department of Nuclear Medicine, University Hospital Essen, Essen, Germany

This study was performed to evaluate a possible artifact related to the administration of intravascular contrast agent in dual-modality PET/CT imaging. Methods: Thirty oncology patients underwent whole-body PET/CT. CT images, which were collected in the presence of intravenous and oral iodinated contrast agent, were used for PET attenuation correction. PET images were assessed for the artifact, defined as a region of high count rate on attenuation-corrected images in accurate coregistration with a contrast-enhanced blood vessel. Intravascular enhancement of thoracic veins was quantified by application of regions of interest, and quantities in patients with the artifact (group 1) and without the artifact (group 2) were correlated. Body surface area was calculated for all patients. Results: The contrast-induced PET artifact was present in 4 (13%) of 30 patients. Mean density differences in intravascular enhancement were highly significant (P < 0.001) in a comparison of group 1 (2,262 ± 304 Hounsfield units [HU]) and group 2 (1,058 ± 209 HU). Body surface area was significantly lower (P = 0.035) in the patients of group 1 (1.67 ± 0.11 m2) than in the patients of group 2 (2.01 ± 0.18 m2). Conclusion: Contrast-enhanced dual-modality PET/CT examinations may result in a PET artifact that is due to the transient bolus passage of undiluted intravenous contrast agent.

Key Words: contrast enhancement • PET/CT • artifact • attenuation




This article has been cited by other articles:


Home page
JNMHome page
D. W. Townsend
Dual-Modality Imaging: Combining Anatomy and Function
J. Nucl. Med., June 1, 2008; 49(6): 938 - 955.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. J. Gollub, R. Hong, D. M. Sarasohn, and T. Akhurst
Limitations of CT During PET/CT
J. Nucl. Med., October 1, 2007; 48(10): 1583 - 1591.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
F. Buther, L. Stegger, M. Dawood, F. Range, M. Schafers, R. Fischbach, T. Wichter, O. Schober, and K. P Schafers
Effective Methods to Correct Contrast Agent-Induced Errors in PET Quantification in Cardiac PET/CT
J. Nucl. Med., July 1, 2007; 48(7): 1060 - 1068.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
W. De Wever, Y. Vankan, S. Stroobants, and J. Verschakelen
Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer
Eur. Respir. J., May 1, 2007; 29(5): 995 - 1002.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. Z. Wong, E. K. Paulson, R. C. Nelson, E. F. Patz Jr., and R. E. Coleman
Practical Approach to Diagnostic CT Combined with PET
Am. J. Roentgenol., March 1, 2007; 188(3): 622 - 629.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. Kuehl, P. Veit, S. J. Rosenbaum, A. Bockisch, and G. Antoch
Can PET/CT Replace Separate Diagnostic CT for Cancer Imaging? Optimizing CT Protocols for Imaging Cancers of the Chest and Abdomen
J. Nucl. Med., January 1, 2007; 48(1_suppl): 45S - 57S.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
J. D. Berry and G. J. R. Cook
Positron emission tomography in oncology
Br. Med. Bull., December 14, 2006; (2006) ldl013v1.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
M. A. Blake, A. Singh, B. N. Setty, J. Slattery, M. Kalra, M. M. Maher, D. V. Sahani, A. J. Fischman, and P. R. Mueller
Pearls and Pitfalls in Interpretation of Abdominal and Pelvic PET-CT
RadioGraphics, September 1, 2006; 26(5): 1335 - 1353.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. Delbeke, R. E. Coleman, M. J. Guiberteau, M. L. Brown, H. D. Royal, B. A. Siegel, D. W. Townsend, L. L. Berland, J. A. Parker, K. Hubner, et al.
Procedure Guideline for Tumor Imaging with 18F-FDG PET/CT 1.0
J. Nucl. Med., May 1, 2006; 47(5): 885 - 895.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Leboulleux, C. Dromain, G. Bonniaud, A. Auperin, B. Caillou, J. Lumbroso, R. Sigal, E. Baudin, and M. Schlumberger
Diagnostic and Prognostic Value of 18-Fluorodeoxyglucose Positron Emission Tomography in Adrenocortical Carcinoma: A Prospective Comparison with Computed Tomography
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 920 - 925.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
O. Mawlawi, J. J. Erasmus, R. F. Munden, T. Pan, A. E. Knight, H. A. Macapinlac, D. A. Podoloff, and M. Chasen
Quantifying the Effect of IV Contrast Media on Integrated PET/CT: Clinical Evaluation
Am. J. Roentgenol., February 1, 2006; 186(2): 308 - 319.
[Abstract] [Full Text] [PDF]


Home page
J. Nucl. Med. Technol.Home page
P. H. Kuo and D. W. Cheng
Artifactual Spinal Metastases Imaged by PET/CT: A Case Report
J. Nucl. Med. Technol., December 1, 2005; 33(4): 230 - 231.
[Abstract] [Full Text] [PDF]


Home page
J. Nucl. Med. Technol.Home page
W. Sureshbabu and O. Mawlawi
PET/CT Imaging Artifacts
J. Nucl. Med. Technol., September 1, 2005; 33(3): 156 - 161.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
F. Gutman, J.-L. Alberini, M. Wartski, D. Vilain, E. Le Stanc, F. Sarandi, C. Corone, C. Tainturier, and A. P. Pecking
Incidental Colonic Focal Lesions Detected by FDG PET/CT
Am. J. Roentgenol., August 1, 2005; 185(2): 495 - 500.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. E. Coleman, D. Delbeke, M. J. Guiberteau, P. S. Conti, H. D. Royal, J. C. Weinreb, B. A. Siegel, M. F. Federle, D. W. Townsend, and L. L. Berland
Concurrent PET/CT with an Integrated Imaging System: Intersociety Dialogue from the Joint Working Group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance
J. Nucl. Med., July 1, 2005; 46(7): 1225 - 1239.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
T. M. Blodgett, M. B. Fukui, C. H. Snyderman, B. F. Branstetter IV, B. M. McCook, D. W. Townsend, and C. C. Meltzer
Combined PET-CT in the Head and Neck: Part 1. Physiologic, Altered Physiologic, and Artifactual FDG Uptake
RadioGraphics, July 1, 2005; 25(4): 897 - 912.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Beyer, G. Antoch, A. Bockisch, and J. Stattaus
Optimized Intravenous Contrast Administration for Diagnostic Whole-Body 18F-FDG PET/CT
J. Nucl. Med., March 1, 2005; 46(3): 429 - 435.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
F. P. DiFilippo and R. C. Brunken
Do Implanted Pacemaker Leads and ICD Leads Cause Metal-Related Artifact in Cardiac PET/CT?
J. Nucl. Med., March 1, 2005; 46(3): 436 - 443.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Y.-Y. Yau, W.-S. Chan, Y.-M. Tam, P. Vernon, S. Wong, M. Coel, and S. K.-F. Chu
Application of Intravenous Contrast in PET/CT: Does It Really Introduce Significant Attenuation Correction Error?
J. Nucl. Med., February 1, 2005; 46(2): 283 - 291.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
A. Gutzeit, G. Antoch, H. Kuhl, T. Egelhof, M. Fischer, E. Hauth, S. Goehde, A. Bockisch, J. Debatin, and L. Freudenberg
Unknown Primary Tumors: Detection with Dual-Modality PET/CT--Initial Experience
Radiology, January 1, 2005; 234(1): 227 - 234.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. Antoch, N. Saoudi, H. Kuehl, G. Dahmen, S. P. Mueller, T. Beyer, A. Bockisch, J. F. Debatin, and L. S. Freudenberg
Accuracy of Whole-Body Dual-Modality Fluorine-18-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Tumor Staging in Solid Tumors: Comparison With CT and PET
J. Clin. Oncol., November 1, 2004; 22(21): 4357 - 4368.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
W. Romer, M. Chung, A. Chan, D. W. Townsend, F. Torok, B. McCook, M. P. Federle, and N. Avril
Single-Detector Helical CT in PET-CT: Assessment of Image Quality
Am. J. Roentgenol., June 1, 2004; 182(6): 1571 - 1577.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. Antoch, J. Kanja, S. Bauer, H. Kuehl, K. Renzing-Koehler, J. Schuette, A. Bockisch, J. F. Debatin, and L. S. Freudenberg
Comparison of PET, CT, and Dual-Modality PET/CT Imaging for Monitoring of Imatinib (STI571) Therapy in Patients with Gastrointestinal Stromal Tumors
J. Nucl. Med., March 1, 2004; 45(3): 357 - 365.
[Abstract] [Full Text]


Home page
RadiologyHome page
G. Antoch, H. Kuehl, J. Kanja, T. C. Lauenstein, H. Schneemann, E. Hauth, W. Jentzen, T. Beyer, S. C. Goehde, and J. F. Debatin
Dual-Modality PET/CT Scanning with Negative Oral Contrast Agent to Avoid Artifacts: Introduction and Evaluation
Radiology, March 1, 2004; 230(3): 879 - 885.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
B. S. Halpern, M. Dahlbom, C. Waldherr, C. S. Yap, C. Schiepers, D. H. Silverman, O. Ratib, and J. Czernin
Cardiac Pacemakers and Central Venous Lines Can Induce Focal Artifacts on CT-Corrected PET Images
J. Nucl. Med., February 1, 2004; 45(2): 290 - 293.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. Antoch, L. S. Freudenberg, T. Beyer, A. Bockisch, and J. F. Debatin
To Enhance or Not to Enhance? 18F-FDG and CT Contrast Agents in Dual-Modality 18F-FDG PET/CT
J. Nucl. Med., January 1, 2004; 45(90010): 56S - 65.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. Antoch, F. M. Vogt, L. S. Freudenberg, F. Nazaradeh, S. C. Goehde, J. Barkhausen, G. Dahmen, A. Bockisch, J. F. Debatin, and S. G. Ruehm
Whole-Body Dual-Modality PET/CT and Whole-Body MRI for Tumor Staging in Oncology
JAMA, December 24, 2003; 290(24): 3199 - 3206.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. A. Nehmeh, Y. E. Erdi, H. Kalaigian, K. S. Kolbert, T. Pan, H. Yeung, O. Squire, A. Sinha, S. M. Larson, and J. L. Humm
Correction for Oral Contrast Artifacts in CT Attenuation-Corrected PET Images Obtained by Combined PET/CT
J. Nucl. Med., December 1, 2003; 44(12): 1940 - 1944.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.